皮切坦诺 - - 它可以用于治疗皮肤色素过高吗?
1Himalayan Pharmacy Institute, Majitar, Sikkim, India.
Pigment cell & melanoma research
|March 17, 2025
概括
皮塞阿坦诺 (PCT) 通过抑制黑色素生成,显示出治疗多颜色的前景. 这一审查探讨了PCT.
科学领域:
- 化品科学 化品科学
- 皮肤病学 皮肤病学
- 自然产品 化学 化学
背景情况:
- 由于安全性和消费者需求,化品行业越来越多地优先考虑天然化合物而不是合成化合物.
- 超色素障碍是一个重大问题,影响皮肤健康和自尊.
- 减少黑色素的产生是针对多色素的化品治疗的重点.
研究的目的:
- 探索和推测上游的信号通路,通过它piceatannol (PCT) 抑制忧郁发生.
- 为了弥补PCT的机制的知识差距,超越氨酶抑制和MITF下调.
- 为了确定潜在的化品和治疗目标的超颜色障碍.
主要方法:
- 文献综述和对Piceatannol (PCT) 和黑色素的现有研究进行分析.
- 探索潜在的上游信号通路,调节MITF表达.
- 对PCT在细胞信号级联中的相互作用进行推测分析.
主要成果:
- 皮塞坦诺 (PCT) 是一种天然化合物,具有治疗多发色素的潜力.
- 已知的PCT机制包括铁酶抑制和MITF下调.
- PCT作用的潜在上游途径包括Nrf,FOXO3a,CREB和MAPK信号传递.
结论:
- 皮塞坦诺利 (PCT) 提供了一种有前途的自然方法来控制多颜色.
- 对PCT上游信号通路的进一步研究可以揭示新的治疗点.
- 这一综述为开发用于超色素的新型化品和皮肤病治疗提供了基础.
相关概念视频
Pigmentation
2.2K
The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
2.2K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
141
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
141


